A Three-Pronged Template Approach for Rapid HPLC Method Development

LCGC North America

Volumn 31, Issue 8, 2013, Pages 612-621

  Dong, Michael W ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885619283     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. L.R. Snyder, J.J. Kirkland, and J.W. Dolan, Introduction to Modern Liquid Chromatography, 3rd Ed. (John Wiley & Sons, Hoboken, New Jersey, 2010), pp. 405-497.
2. M.W. Dong, Modern HPLC for Practicing Scientists (Wiley, Hoboken, New Jersey, 2006), pp. 193-220.
3. L.R. Snyder, J.J. Kirkland, and J.L. Glajch, Practical HPLC Method Development (John Wiley & Sons, New York, 1997).
4. S. Matthew, Analytical Method Development by HPLC for Starters, 1st Ed. (E-book from http://Amazon.com/, Amazon Digital Services, Inc., Seattle, Washington, 2012).
5. M.E. Swartz and I. Krull, Analytical Method Development and Validation, 1st Ed. (CRC Press, Boca Raton, Florida, 1997).
6. H.T. Rasmussen, Q.Y. Li, D. Redlich, and M.I. Jimidar, in Handbook of Pharmaceutical Analysis by HPLC, S. Ahuja and M.W. Dong, Eds. (Elsevier/Academic Press, Amsterdam, Netherlands, 2005), pp. 145-191.
7. R. LoBrutto, in HPLC for Pharmaceutical Scientists, Y.V. Kazakevich and R. LoBrutto, Eds. (Wiley, Hoboken, New Jersey, 2007), pp. 347-454.
8. D. Guillarme and M.W. Dong, Amer. Pharm. Rev. 16(4), 36-43 (2013).
9. L.R. Snyder, LCGC North Am. 25(8), 437-444 (2012).
10. Y. Li, G.T. Terfloth, and A.S. Kord, Amer. Pharm. Rev. 12(4), 87-95 (2009).
11. ICH Harmonized Tripartite Guideline, Impurities in new drug substances, Q3A (R2), 25 October 2006, ICH Expert Working Group.
12. M.W. Dong, E.X. Zhao, D.T. Yazzie, C.C. Gu, and J.D. Pellett, Amer. Pharm. Rev. 15(6), 10-17 (2012).
13. M.W. Dong, LCGC North Am. 31(6), 472-479 (2013).
14. M.W. Dong, LCGC North Am. 25(7), 656-666 (2007).
15. L.R. Snyder and J.W. Dolan, High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model (Wiley, Hoboken, New Jersey, 2006).
16. M.W. Dong, D. Guillarme, S. Fekete, R. Rangelova, J. Richards, D. Prudhomme, and N.P. Chetwyn, J. Pharm. Biomed. Anal., submitted.
17. J. Ruta, D. Guillarme, S. Rudaz, and J.L. Veuthey, J. Sep. Sci. 33, 2465-2477 (2010).